Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY (Tables)

v3.22.0.1
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Dec. 31, 2021
Equity [Abstract]  
SCHEDULE OF STOCK WARRANT ACTIVITY

Warrant detail for the six months ended December 31, 2021 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2021     214,883     $ 4.49       2.92  
Warrants issued     1,071,430     $ 7.00       5.00  
Warrants outstanding and exercisable at December 31, 2021     1,286,313     $ 6.58       4.35  

 

Warrant detail for the six months ended December 31, 2020 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2020     83,205     $ 4.00       2.01  
Warrants issued     185,955     $ 4.80       5.00  
Warrants outstanding at December 31, 2020     269,160     $ 4.55       3.66  
Warrants exercisable at December 31, 2020     83,205     $ 4.00       1.50  
SCHEDULE OF STOCK OPTIONS ACTIVITY

Activity in the Company’s stock options during the six months ended December 31, 2021 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2021     531,205     $ 11.02       6.73  
Granted     -     $ -       -  
Exercised     (3,400 )   $ 4.65       -  
Forfeited and cancelled     (14,199 )   $ 13.70       -  
Outstanding at December 31, 2021     513,606     $ 10.99       6.20  
Exercisable at December 31, 2021     500,623     $ 10.95       6.16  

 

Activity in the Company’s stock options during the six months ended December 31, 2020 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020     579,584     $ 11.00       7.55  
Granted     -     $ -       -  
Exercised     (10,750 )   $ 4.60       -  
Forfeited and cancelled     (7,463 )   $ 7.31       -  
Outstanding at December 31, 2020     561,371     $ 11.17       6.87  
Exercisable at December 31, 2020     493,224     $ 10.94       6.67  
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY

Activity in RSUs during the six months ended December 31, 2021 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Grant date Fair Value    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2021     131,652     $ 9.25       2.72  
Granted     179,614     $ 5.75       -  
Forfeited and cancelled     (18,334 )   $ 7.71       -  
Outstanding at December 31, 2021     292,932     $ 7.22       2.69  

 

 

Activity in RSUs during the six months ended December 31, 2020 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Grant date Fair Value    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020     -     $ -       -  
Granted     134,865     $ 8.88       -  
Forfeited and cancelled     (4,228 )   $ 8.88       -  
Outstanding at December 31, 2020     130,637     $ 8.88       3.15  
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES

The following table summarizes stock-based compensation expense for employee and non-employee stock option and RSU grants:

 

   

Three Months Ended
December 31,

   

Six Months Ended
December 31,

 
    2021     2020     2021     2020  
Research and development   $ 54,000     $ 45,000     $ 90,000     $ 98,000  
Selling and administrative     195,000       152,000       359,000       324,000  
Total stock-based compensation expense   $ 249,000     $ 197,000     $ 449,000     $ 422,000